<SEC-DOCUMENT>0001493152-22-017509-index.html : 20220622
<SEC-HEADER>0001493152-22-017509.hdr.sgml : 20220622
<ACCEPTANCE-DATETIME>20220622170113
ACCESSION NUMBER:		0001493152-22-017509
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20220621
FILED AS OF DATE:		20220622
DATE AS OF CHANGE:		20220622

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Dorval Allison
		CENTRAL INDEX KEY:			0001625110

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40544
		FILM NUMBER:		221032729

	MAIL ADDRESS:	
		STREET 1:		C/O INSULET CORPORATION
		STREET 2:		600 TECHNOLOGY PARK DRIVE, SUITE 200
		CITY:			BILLERICA
		STATE:			MA
		ZIP:			01821

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aerovate Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001798749
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				831377888
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		200 BERKELEY STREET
		STREET 2:		FLOOR 18
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
		BUSINESS PHONE:		617-443-2400

	MAIL ADDRESS:	
		STREET 1:		200 BERKELEY STREET
		STREET 2:		FLOOR 18
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02116
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
Document 1 - file: ownership.html

Document 1 - RAW XML: ownership.xml

</DOCUMENT>
</SEC-DOCUMENT>